Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/VSBC/Capital expenditures

VITASPRING BIOMEDICAL CO., LTD. (VSBC) Capital expenditures 2022–2023

VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$0FY2023 · since FY2022: $72,997 → $0
2223
Fiscal yearValueYoY
FY2023$0-100.0%
FY2022$72,997—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More VSBC financial trends

VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating marginVSBC Operating cash flowVSBC Free cash flowVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →